glp-1 and naion Ophthalmic Complications Observed After Use of Agonists GLP-1 Ocular Manifestations and NAION

Brown L, et al

This is an area where the mechanism is well-characterized, the animal data is robust, and the safety profile appears favorable, but rigorous human trial data remains limited

Forms of Glutathione L-glutathione is present in cells and tissues in reduced (GSH) and oxidized (GSSG and glutathione disulfide) forms

Our group found MC4-NN20453 acts as a full agonist on hMC4R (EC 50 = 31 nM, E max = 105%) but only had partial agonist activity at hMC3R (EC 50 = 39 nM, E max = 31%) ( Conde-Frieboes et al

These new products can harm your eyes and your wallet

While much of the available data comes from preclinical studies, interest in its biological activity continues to grow due to its interaction with multiple physiological pathways